GlassScriptPhysician profile
Derek W Delmonte
NPI 1528225471
$26,956.32
in general payments reported to CMS, 2019-2025
22 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,034 · 2020: $2,157 · 2021: $199 · 2022: $1,009 · 2023: $1,591 · 2024: $6,323 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $3,001 · Travel and Lodging: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,350.00 |
| Food and Beverage | $3,001.36 |
| Travel and Lodging | $2,205.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $19,724.75 | 2019-2025 | Epioxa, Ce-Marked Kxla System, Kxl System |
| Johnson & Johnson Surgical Vision, INC. | $3,891.18 | 2019-2022 | |
| Alcon Vision LLC | $1,301.13 | 2019-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Rxsight INC | $314.52 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Abbvie INC. | $227.91 | 2022-2025 | Ozurdex |
| Bausch & Lomb Americas INC. | $196.70 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| New World Medical,INC. | $151.08 | 2023 | |
| Astellas Pharma US INC | $147.58 | 2023-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $143.61 | 2022-2024 | Eylea Hd |
| Microsurgical Technology, INC. | $132.79 | 2022 | |
| Amgen INC. | $124.78 | 2024-2025 | Tepezza |
| Nova Eye, INC. | $100.11 | 2025 | |
| Oyster Point Pharma, INC. | $96.48 | 2022 | |
| Allergan, INC. | $95.38 | 2022 | |
| Eyepoint US, INC. | $65.41 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $64.80 | 2019 | |
| Harrow Eye, LLC | $55.28 | 2025 | Iheezo |
| Ani Pharmaceuticals, INC. | $33.59 | 2022-2023 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $31.48 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $28.91 | 2021 | |
| Omeros Corporation | $16.87 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Delmonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.